Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy (vol 117, pg 858, 2001)

被引：0
作者：
Pellet, C
Chevret, S
Blum, L
Gauville, C
Hurault, M
Blanchard, G
Agbalika, F
Lascoux, C
Ponscarme, D
Morel, P
Calvo, F
Lebbe, C
机构：
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2002年 / 118卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：741 / 741
页数：1
相关论文
共 50 条
  • [31] Rapidly eruptive, treatment-resistant, nodular Kaposi's sarcoma in an acquired immunodeficiency syndrome (AIDS) patient on highly active antiretroviral therapy
    Chang, Caroline A.
    Sanchez, Miguel R.
    Karen, Julie K.
    Rosenman, Karla S.
    Prystowsky, Stephen D.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (02) : 173 - 174
  • [32] The role of immune restoration using highly active antiretroviral therapy in the management of AIDS-related Kaposi's sarcoma coexisting with pulmonary tuberculosis
    Abdullahi, Umar
    Adeiza, Mukhtar Abdulmajid
    NIGERIAN POSTGRADUATE MEDICAL JOURNAL, 2020, 27 (01) : 63 - 66
  • [33] Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings
    Epeldegui, Marta
    Chang, Di
    Lee, Jeannette
    Magpantay, Larry I.
    Borok, Margaret
    Bukuru, Aggrey
    Busakhala, Naftali
    Godfrey, Catherine
    Hosseinipour, Mina C.
    Kang, Minhee
    Kanyama, Cecilia
    Langat, Deborah
    Mngqibisa, Rosie
    Mwelase, Noluthando
    Nyirenda, Mulinda
    Samaneka, Wadzanai
    Hoagland, Brenda
    Campbell, Thomas B.
    Martinez-Maza, Otoniel
    Krown, Susan E.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 94 (02) : 165 - 173
  • [34] Effect of Directly Observed Therapy for Highly Active Antiretroviral Therapy on Virologic, Immunologic, and Adherence Outcomes: A Meta-Analysis and Systematic Review (vol 54, pg 167, 2010)
    Hart
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (01) : E37 - E38
  • [35] Highly active antiretroviral therapy for the treatment of Kaposi's sarcoma associated with primary human immunodeficiency virus type-1 infection
    Genka, I
    Yasuoka, A
    Saitoh, K
    Oka, S
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2000, 53 (04) : 166 - 167
  • [36] The immunological effects of concomitant highly active antiretroviral therapy and liposomal anthracycline treatment of HIV-1-associated Kaposi's sarcoma
    Esdaile, B
    Davis, M
    Portsmouth, S
    Sarker, D
    Nelson, M
    Gazzard, B
    Bower, M
    AIDS, 2002, 16 (17) : 2344 - 2347
  • [37] Fatal Kaposi's sarcoma-associated immune reconstitution following highly active antiretrovial therapy. (vol 16, pg 582, 2005)
    Kawsar, M
    INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (10) : 714 - 714
  • [38] The Response of HIV-Associated Lymphadenopathic Kaposi Sarcoma to Highly Active Antiretroviral Therapy Evaluated by 18F-FDG PET/CT
    Mankia, Satveer K.
    Miller, Robert F.
    Edwards, Simon G.
    Ramsay, Alan
    Lee, Siow Ming
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (07) : 692 - 693
  • [39] Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS - Patients on highly active antiretroviral therapy
    Boivin, G
    Gaudreau, A
    Routy, JP
    AIDS, 2000, 14 (13) : 1907 - 1910
  • [40] Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD)
    Oyomopito, R.
    Lee, M. P.
    Phanuphak, P.
    Lim, P. L.
    Ditangco, R.
    Zhou, J.
    Sirisanthana, T.
    Chen, Y. M. A.
    Pujari, S.
    Kumarasamy, N.
    Sungkanuparph, S.
    Lee, C. K. C.
    Kamarulzaman, A.
    Oka, S.
    Zhang, F. J.
    Mean, C. V.
    Merati, T.
    Tau, G.
    Smith, J.
    Li, P. C. K.
    HIV MEDICINE, 2010, 11 (08) : 519 - 529
12345